Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2015 Mar 16;10(3):e0120831. doi: 10.1371/journal.pone.0120831

Correction: Evaluating the Cost-Effectiveness of Lifestyle Modification versus Metformin Therapy for the Prevention of Diabetes in Singapore

The PLOS ONE Staff
PMCID: PMC4361762  PMID: 25774690

In Table 6, the value of ICER of metformin intervention (Health system) at QALY = 2.09 should be 2,489. Please see the corrected Table 6 here.

Table 6. One-way sensitivity analysis of metformin intervention’s effectiveness.

ICER of metformin intervention (Health system) ICER of metformin intervention (Societal)
Cost of metformin intervention 8,331 26,728
QALY
1.79 Dominated Dominated
1.89 Dominated Dominated
1.99 21,065 6,367
2.09 2,489 752
2.19 1,323 400

QALY: quality adjusted life years; ICER: incremental cost-effectiveness ratio (in 2012US$ per QALY)

Reference


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES